No abstract available.
Parturition* ; Vital Statistics*

Pheochromocytoma is the cause of hypertension in 0.1% of the hypertencive patits, and in 10% of these cases, the tumor is bilateral. Therefore bilateral pheochromocytoma is very rare. The following is a report of the anesthetic methods employed in the surgical management of a case of bilateral pheochromocytoma which was performed in stages at PNUH, between June 4th and June 12, 1986. The staged operation reduced the instability of the vital signs caused by concurrent manipulation of the bilateral pheochromoytoma and facilitated tumor removal.
Hypertension ; Pheochromocytoma* ; Vital Signs

Pheochromocytoma is the cause of hypertension in 0.1% of the hypertencive patits, and in 10% of these cases, the tumor is bilateral. Therefore bilateral pheochromocytoma is very rare. The following is a report of the anesthetic methods employed in the surgical management of a case of bilateral pheochromocytoma which was performed in stages at PNUH, between June 4th and June 12, 1986. The staged operation reduced the instability of the vital signs caused by concurrent manipulation of the bilateral pheochromoytoma and facilitated tumor removal.
Hypertension ; Pheochromocytoma* ; Vital Signs

The hypnotic activity of diazepam was compared with that of inactive placebo in a double- blind, randomized study in 40 surgical patients the night before their scheduled procedures. Diazepam per os (10mg) produces a pattern of response that differed markedly from that of the placebo. The patient receiving diazepam fell asleep sooner, slept more soundly and steadily and more felt they had been helped to sleep, while fewer awoke during the night. The significant difference Was obtained in both hypnotic and ataractic effects between diazepam and inactive placebo. Neither diaxepam nor inactive placbo caused marked changes in vital signs or any serious side effects.
Diazepam* ; Humans ; Vital Signs

OBJECTIVES: The objective of this study was to evaluate the efficacy of Unicenta (UNCNT) and Melsmon in women with the menopausal symptoms, by analysing the changes in the Kupperman index (primary endpoint), and the hormonal change (secondary endpoint). METHODS: This is a randomized, multi-Center, double-Blind, parallel, non-inferiority clinical study of four different tertiary medical centers. We began the participant recruitment in September 2011, with 218 patients applied over 7 months. All participants had the last visit in April 2012. RESULTS: The Unicenta injection was not inferior to that of Melsmon as measured by the Kupperman index following the injection in both the intent-to-treat and the per-protocol populations (P = 0.63, P = 0.85, respectively). Side effects occurred in 14.0% of the cases (15 patients/18 cases) in the case group, and in 12.6% (14 patients/15 cases) in the control group (P value=0.7599). None were reported to be associated with the medication. The laboratory results and the vital signs showed no statistically significant risk for safety. CONCLUSION: The study showed that Unicenta is not inferior to Melsmon in the change of the Kupperman index after 12 days of injection. The efficacy and safety of Unicenta was shown, with the improvement of the menopausal symptoms.
Female ; Humans ; Menopause ; Vital Signs

BACKGROUND/AIMS: For proper sedation during endoscopic submucosal dissection (ESD), propofol has been widely used. This study aimed to compare the levels of sedation and tolerance of patients treated with midazolam (M group) and a combination of midazolam and propofol (MP group) during ESD. METHODS: A total of 44 consecutive patients undergoing ESD were randomly assigned to the two groups. In the M group, 2 mg of midazolam was given repeatedly to maintain after a loading dose of 5 mg. The MP group initially received 5 mg of midazolam and 20 mg of propofol. Then, we increased the dosage of propofol by 20 mg gradually. RESULTS: The average amount of midazolam was 12 mg in the M group. In the M group, 10 patients were given propofol additionally, since they failed to achieve proper sedation. The average amount of propofol was 181 mg in the MP group. Procedure time, vital signs and rates of complications were not significantly different between two groups. Movement of patients and discomfort were lower in the MP group. CONCLUSIONS: During ESD, treatment with propofol and a low dose of midazolam for sedation provides greater satisfaction for endoscopists compared to midazolam alone.
Humans ; Midazolam ; Propofol ; Vital Signs

BACKGROUND/AIMS: For proper sedation during endoscopic submucosal dissection (ESD), propofol has been widely used. This study aimed to compare the levels of sedation and tolerance of patients treated with midazolam (M group) and a combination of midazolam and propofol (MP group) during ESD. METHODS: A total of 44 consecutive patients undergoing ESD were randomly assigned to the two groups. In the M group, 2 mg of midazolam was given repeatedly to maintain after a loading dose of 5 mg. The MP group initially received 5 mg of midazolam and 20 mg of propofol. Then, we increased the dosage of propofol by 20 mg gradually. RESULTS: The average amount of midazolam was 12 mg in the M group. In the M group, 10 patients were given propofol additionally, since they failed to achieve proper sedation. The average amount of propofol was 181 mg in the MP group. Procedure time, vital signs and rates of complications were not significantly different between two groups. Movement of patients and discomfort were lower in the MP group. CONCLUSIONS: During ESD, treatment with propofol and a low dose of midazolam for sedation provides greater satisfaction for endoscopists compared to midazolam alone.
Humans ; Midazolam ; Propofol ; Vital Signs

PURPOSE: To separately evaluate the respiratory function of both lungs separately in patients with unilateralmain bronchial stenosis or obstruction, applying respiratory dynamic CT using the spiral technique. MATERIALS AND METHODS: This study involved five normal subjects and six patients with main bronchial stenosis. Time-continuous scan data at a selected levels during forced vital capacity maneuver were obtained, and static images were retrospectively reconstructed using 0.67 sec. partial scan data per image. Time-density curves for controls and patients were plotted and compared. RESULTS: The highest values of mean attenuation were -697+/-9 H for the leftlung and -684+/-9 H for the right lung of controls, and -697+/-5HU for the healthy lung and -791+/-3H for thediseased lung of the patients. The lowest values were -837+/-2H for the left lung and -842+/-5H for the right lungof contorls, and -847+/-0H for the healthy lung and -858+/-4H for the diseased lung of patients. Mean durations ofexpiration were 1.64+/-.65 seconds for the left lung and 1.58+/-.50 seconds for the right lung of controls, and1.66+/-.60 seconds for the healthy lung and 1.96±.49 seconds for the diseased lung of patients. Time-attenuationcurves for the right and left lung of controls were not significautly different, but except for the lowest value of mean attenuation, these were signficantly different for the healthy and diseased longs of patients. CONCLUSION: Respiratory dynamic CT is an updated technique which permits imaging of the functional status of lung parenchy maduring respiration. It may be useful in the evaluation and quantification of lung function in patients with proximal airway stenosis.
Constriction, Pathologic* ; Humans ; Lung ; Respiration ; Vital Capacity

BACKGROUND: It has been sugested that excessive airway narrowing in asthma may be detected by a decrease in forced vital capacity (FVC). A volume differrence between slow vital capacity (SVC) and FVC may be used as a surrogate index of airway collapse. OBJECTIVE: To investigate the relationship between an airway collapsibility index (CI) and airflow limitation or airway hyperresponsiveness in asthma. METHODS: Forty-six patients with suspected asthma and 21 normal control subjects were enrolled. CI was defined as a difference between SVC and FVC, and measured before and after a methacholine (MCh) bronchoprovocation test. Positive response to MCh was defined as a fall of FEV1 by more than 12%. RESULTS: CI significantly increased from 1.10+/-3.86% to 5.52+/-7.91% after MCh in the positive MCh group (n=19, p<0.01). Not only FVC but also SVC was significantly decreased after MCh. One-fifth of the decrease in FVC was caused by the increase in CI. Both FVC and SVC were significantly related to baseline FEV1 values and in percent change after MCh. Although CI was also significantly related to FEV1 in percent change after MCh. CI was significantly higher in the positive MCh group than in the control and was not significantly related to baseline FEV1 values. Furthermore, the relationship of CI values between before and after MCh was significant (r=0.622, p<0.01). CI was not significantly different according to the severity of MCh-PC20. CONCLUSION: Because the relationship between CI and the severity of airflow limitation or MCh-PC20 was less significant. CI may be better than FVC to represent the characteristic of excessive airway narrowing in asthma.
Asthma* ; Humans ; Methacholine Chloride ; Vital Capacity

We report a case of left adrenal pheochromocytoma in 17-year-old girl, we observed all of vital sign were returned to normal in 19-th postoperative day
Adolescent ; Female ; Humans ; Pheochromocytoma* ; Vital Signs